Assembly and immunogenicity of coronavirus-like particles carrying infectious bronchitis virus M and S proteins

Vaccine

Volumn 31, Issue 47, 2013, Pages 5524-5530

  Liu, Genmei ^a   Lv, Lishan ^a   Yin, Lijuan ^a   Li, Xiaoming ^a   Luo, Dongu ^a   Liu, Kang ^a   Xue, Chunyi ^a   Cao, Yongchang ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Infectious bronchitis virus; Vaccine; VLPs

Indexed keywords

CYTOKINE; DNA; FREUND ADJUVANT; GENTAMICIN; INACTIVATED VACCINE; INFECTIOUS BRONCHITIS VIRUS VACCINE; INTERFERON; INTERLEUKIN 4; NEUTRALIZING ANTIBODY; STRUCTURAL PROTEIN; UNCLASSIFIED DRUG; VIRUS M PROTEIN; VIRUS PROTEIN; VIRUS S PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; AVIAN INFECTIOUS BRONCHITIS VIRUS; BACULOVIRUS; CELL LYSATE; CHICKEN; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORONAVIRUS; CYTOKINE RELEASE; ELECTRON MICROSCOPY; ENZYME LINKED IMMUNOSPOT ASSAY; GENE EXPRESSION; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; POULTRY; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; RECOMBINANT PLASMID; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA VIRUS; SF9 CELL; SPLEEN; VIRUS LIKE AGENT; VIRUS RECOMBINANT; WESTERN BLOTTING;

INFECTIOUS BRONCHITIS VIRUS; VACCINE; VLPS;

ANIMALS; ANTIBODIES, VIRAL; BACULOVIRIDAE; CHICKENS; CORONAVIRUS INFECTIONS; INFECTIOUS BRONCHITIS VIRUS; LYMPHOCYTES; MICE; POULTRY DISEASES; SF9 CELLS; SPIKE GLYCOPROTEIN, CORONAVIRUS; SPODOPTERA; VACCINES, SYNTHETIC; VACCINES, VIRUS-LIKE PARTICLE; VIRAL MATRIX PROTEINS; VIRAL VACCINES;

EID: 84886780209     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.09.024     Document Type: Article

References (28)

1. de Haan C.A., Vennema H., Rottier P.J. Assembly of the coronavirus envelope: homotypic interactions between the M proteins. J Virol 2000, 74:4967-4978.
2. Hogue B.G., Machamer C.E. Coronavirus structural proteins and virus assembly. Nidoviruses 2008, 179-200. ASM Press, Washington, DC. S. Perlman, T. Gallagher, E.J. Snijder (Eds.).
3. Masters P.S. The molecular biology of coronaviruses. Adv Virus Res 2006, 66:193-292.
4. Nguyen V.P., Hogue B.G. Protein interactions during coronavirus assembly. J Virol 1997, 71:9278-9284.
5. Machamer C.E., Mentone S.A., Rose J.K., Farquhar M.G. The E1 glycoprotein of an avian coronavirus is targeted to the cis Golgi complex. Proc Natl Acad Sci U S A 1990, 87:6944-6948.
6. Corse E., Machamer C.E. Infectious bronchitis virus E protein is targeted to the Golgi complex and directs release of virus-like particles. J Virol 2000, 74:4319-4326.
7. Tseng Y.T., Wang S.M., Huang K.J., Lee A.I., Chiang C.C., Wang C.T. Self-assembly of severe acute respiratory syndrome coronavirus membrane protein. J Biol Chem 2010, 285:12862-12872.
8. Huang Y., Yang Z.Y., Kong W.P., Nabel G.J. Generation of synthetic severe acute respiratory syndrome coronavirus pseudoparticles: implications for assembly and vaccine production. J Virol 2004, 78:12557-12565.
9. Cavanagh D., Davis P.J., Darbyshire J.H., Peters R.W. Coronavirus IBV: virus retaining spike glycopolypeptide S2 but not S1 is unable to induce virus-neutralizing or haemagglutination-inhibiting antibody, or induce chicken tracheal protection. J Gen Virol 1986, 67(Pt. 7):1435-1442.
10. Ignjatovic J., Galli L. Structural proteins of avian infectious bronchitis virus: role in immunity and protection. Adv Exp Med Biol 1993, 342:449-453.
11. Ignjatovic J., Galli L. The S1 glycoprotein but not the N or M proteins of avian infectious bronchitis virus induces protection in vaccinated chickens. Arch Virol 1994, 138:117-134.
12. Ignjatovic J., Galli U. Immune responses to structural proteins of avian infectious bronchitis virus. Avian Pathol 1995, 24:313-332.
13. Kant A., Koch G., van Roozelaar D.J., Kusters J.G., Poelwijk F.A., van der Zeijst B.A. Location of antigenic sites defined by neutralizing monoclonal antibodies on the S1 avian infectious bronchitis virus glycopolypeptide. J Gen Virol 1992, 73(Pt. 3):591-596.
14. Koch G., Hartog L., Kant A., van Roozelaar D.J. Antigenic domains on the peplomer protein of avian infectious bronchitis virus: correlation with biological functions. J Gen Virol 1990, 71(Pt. 9):1929-1935.
15. Vennema H., Heijnen L., Zijderveld A., Horzinek M.C., Spaan W.J. Intracellular transport of recombinant coronavirus spike proteins: implications for virus assembly. J Virol 1990, 64:339-346.
16. Godeke G.J., de Haan C.A., Rossen J.W., Vennema H., Rottier P.J. Assembly of spikes into coronavirus particles is mediated by the carboxy-terminal domain of the spike protein. J Virol 2000, 74:1566-1571.
17. Kushnir N., Streatfield S.J., Yusibov V. Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development. Vaccine 2012, 31:58-83.
18. Corse E., Machamer C.E. The cytoplasmic tails of infectious bronchitis virus E and M proteins mediate their interaction. Virology 2003, 312:25-34.
19. Metsikko K., van Meer G., Simons K. Reconstitution of the fusogenic activity of vesicular stomatitis virus. EMBO J 1986, 5:3429-3435.
20. Stegmann T., Morselt H.W., Booy F.P., van Breemen J.F., Scherphof G., Wilschut J. Functional reconstitution of influenza virus envelopes. EMBO J 1987, 6:2651-2659.
21. Yin Z., Liu J. Animal virology 1997, Beijing Science Press, Beijing. second ed.
22. Ho Y., Lin P.H., Liu C.Y., Lee S.P., Chao Y.C. Assembly of human severe acute respiratory syndrome coronavirus-like particles. Biochem Biophys Res Commun 2004, 318:833-838.
23. Siu Y.L., Teoh K.T., Lo J., Chan C.M., Kien F., Escriou N., et al. The M, E, and N structural proteins of the severe acute respiratory syndrome coronavirus are required for efficient assembly, trafficking, and release of virus-like particles. J Virol 2008, 82:11318-11330.
24. Nakauchi M., Kariwa H., Kon Y., Yoshii K., Maeda A., Takashima I. Analysis of severe acute respiratory syndrome coronavirus structural proteins in virus-like particle assembly. Microbiol Immunol 2008, 52:625-630.
25. Liu Y.V., Massare M.J., Barnard D.L., Kort T., Nathan M., Wang L., et al. Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV. Vaccine 2011, 29:6606-6613.
26. Vennema H., Godeke G.J., Rossen J.W., Voorhout W.F., Horzinek M.C., Opstelten D.J., et al. Nucleocapsid-independent assembly of coronavirus-like particles by co-expression of viral envelope protein genes. EMBO J 1996, 15:2020-2028.
27. Bright R.A., Carter D.M., Daniluk S., Toapanta F.R., Ahmad A. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin. Vaccine 2007, 25:3871-3878.
28. McBurney S.P., Young K.R., Ross T.M. Membrane embedded HIV-1 envelope on the surface of a virus-like particle elicits broader immune responses than soluble envelopes. Virology 2007, 358:334-346.